Preview @cp-immunity.bsky.social @camilahcoelho.bsky.social Universal vaccines? Only if your antibody genes agree www.cell.com/immunity/ful... @ki.se www.cell.com/immunity/ful... www.cell.com/immunity/ful...
Camila Coelho, PhD MBA
@camilahcoelho.bsky.social
Human B cell responses to emerging pathogens 🦠 Icahn School of Medicine at Mount Sinai, NYC 🏙 🚕 🗽🍎 www.coelholab.com
🔬 Fellow Spotlight: Dr. Camila Coelho @camilahcoelho.bsky.social Our latest Spotlight blog features Dr. Coelho's work decoding human B cell responses to emerging viruses — and her commitment to making science more accessible everywhere. Read more: keysym.us/CoelhoSpotli... #KSFellows #WIS
Keystone Symposia Fellow Spotlight: Dr. Camila Coelho
Explore Dr. Camila Coelho’s groundbreaking research on human immunology and her commitment to global health, mentorship, and accessible science.
keysym.us
The problem with the whole 'post a woman author you've read 5 books by' is how many women don't get a second book, let alone five. Anyway, carry on.
Incredibly grateful to hear a beautiful invited talk from Dr Camila Coelho @camilahcoelho.bsky.social from Mount Sinai, NY🗽, revealing the first monoclonal antibody protective against an orthopoxvirus, for developing drugs and vaccines against Mpox which urgently needs new therapies 💉✨ #lorneiandi
What an honor! Thank you very much @aai.org, and I can't wait to see everyone in Boston!
The American Association of Immunologists@aai.org · 9mo agoAAI congratulates the 2026 AAI ASPIRE Awardees! This award recognizes their outstanding research accomplishments and professional promise in the field of immunology. Join us to honor them at IMMUNOLOGY2026™: https://immunology2026.aai.org/career-awards/.
We have a new episode out! Dr. @camilahcoelho.bsky.social from Icahn School of Medicine talks about her lab’s work on mpox and other emerging viruses, her approach to #mentorship, and how her MBA education helps her in science. Listen now: bit.ly/43M7r4x
Three monoclonal antibodies targeting the mpox virus protein A35 have shown strong protection against severe disease in laboratory and animal models, indicating potential for new therapeutic approaches. doi.org/g9zg4h
Three potent human antibodies against mpox pave way for new protective therapies
A team from the Microbiology Department at the Icahn School of Medicine at Mount Sinai has discovered three powerful monoclonal antibodies from a person who had previously been infected with mpox (formerly known as monkeypox).
medicalxpress.com
Human monoclonal antibodies targeting A35 protect from death caused by monkeypox virus @cellcellpress.bsky.social @carolilucas.bsky.social @vivianasimonlab.bsky.social @mschotsaert.bsky.social www.cell.com/cell/fulltex...
It starts in 10 minutes! Link below👇 isv-online.org/event/isv-au...
Speeding up vaccine design and antibody discovery using cryoEM and AI/ML
Title:Speeding up vaccine design and antibody discovery using cryoEM and AI/ML Speaker: Andrew Ward, Scripps Research, United States MODERATOR: Camila Coelho, Icahn School of Medicine at Mou...
isv-online.org
4/ Structural studies revealed all 3 mAbs target a highly conserved epitope in the A35 dimer groove, shared across orthopoxviruses. This explains their breadth and potency.
7/ Together, our findings establish A35 as a critical therapeutic target for mpox and related orthopoxviruses, paving the way for next-generation antibody therapies and improved vaccines.
🚨New Paper in Cell 🧵🔎 Happy to share our work led by the @camilahcoelho.bsky.social, on mAbs against mpox. We were very excited (and lucky!) to contribute to this collab. effort. 🦠“Human monoclonal antibodies targeting A35 protect from death caused by mpox”🦠 doi.org/10.1016/j.cell.2025.08.004
🚨 New article! Our study "Human monoclonal antibodies protect against death caused by mpox" is now published: 👉 www.cell.com/cell/fulltex... [1/9]
Human monoclonal antibodies targeting A35 protect from death caused by mpox
Three potent mAbs against the conserved MPXV A35 protein block viral spread, protect against lethal infection in mice, and align with protective antibody responses in convalescent humans, establishing...
cell.com
Such a great time at the #IUIS2025! Inspiring conferences by amazing scientists such as @belkaidlab.bsky.social @virusesimmunity.bsky.social @linterman.bsky.social. Also loved seeing rising stars like @camilahcoelho.bsky.social @marionbrunck.bsky.social. Thanks to James Allison for his lecture !! ❤️
Congratulations to former LJI trainee Dr. Camila Coelho (now at the Icahn School of Medicine at Mount Sinai)! 🎉 Dr. Coelho has been named a "Rising Star" by Union of Immunological Societies — an award for early-stage researchers who are revolutionizing the field! bit.ly/4mGyF3H #health #medicine
Camila Coelho, PhD, MBA, Named Rising Star by Union of Immunological Societies
bit.ly
🚨 New Publication!!! I’m thrilled to share our latest study, “Clonotype-Enriched Somatic Hypermutations Drive Affinity Maturation of a Public Human Antibody Targeting an Occluded Sarbecovirus Epitope”. www.cell.com/cell-reports... [1/4]
Clonotype-enriched somatic hypermutations drive affinity maturation of a public human antibody targeting an occluded sarbecovirus epitope
Rao et al. demonstrate that convergent somatic hypermutations in the light chain, enriched within a sarbecovirus-specific public antibody clonotype, drive affinity maturation. This antibody targets a ...
cell.com
Had a great time presenting my PhD work so far in @camilahcoelho.bsky.social’s lab at the Keystone Vaccinology meeting! Grateful for the chance to share and learn alongside such an inspiring community of scientists! #KSVaccines25
Labels matter and they influence policy. Thank you to the brilliant @camilahcoelho.bsky.social for making us rethink our default scientific terms to take away the unintended stigma to create a safer space. People like you help change the world.
Camila Coelho, PhD MBA@camilahcoelho.bsky.social · last yr.Check our important piece below 👇! "We urge authors, reviewers, and editors to revise the default use of MSM as an epidemiological label. Our intention is not to dismiss important epidemiological context but to prevent the stigmatization of affected populations." @thelancetinfdis.bsky.social
We urge researchers, editors, and public health professionals to: – Reassess default epidemiological labels – Prioritize accuracy over legacy language – Center transmission routes, not identities #PublicHealth #Mpox #InfectiousDiseases #StigmaFreeScience
Check our important piece below 👇! "We urge authors, reviewers, and editors to revise the default use of MSM as an epidemiological label. Our intention is not to dismiss important epidemiological context but to prevent the stigmatization of affected populations." @thelancetinfdis.bsky.social
A call to move beyond MSM-centric framing in mpox research
The resurgence of mpox poses urgent public health challenges, and the scientific community has mobilised admirably to understand its transmission, immunity, and therapeutics.1,2 However, the language ...
thelancet.com
Carolina Lucas@carolilucas.bsky.social · last yr.Words matter. Scientific language shapes public perception and policy. Framing mpox as a disease of GBMSM may have reflected early patterns, but continuing this narrative misrepresents transmission risks and reinforces stigma. With Camila Coelho, Vries & Zucker 🌈 www.thelancet.com/journals/lan...